Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Future developments in thrombolytic therapy]

C Bode1, M S Runge

  • 1Medizinische Klinik III, Universität Heidelberg.

Zeitschrift Fur Kardiologie
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usability and feasibility of E-nergEYEze: a blended vision-specific E-health based cognitive behavioral therapy and self-management intervention to reduce fatigue in adults with visual impairment.

BMC health services research·2023
Same author

Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.

West African journal of medicine·2023
Same author

The effectiveness of motivational interviewing on adherence to wearing orthopedic shoes in people with diabetes at low-to-high risk of foot ulceration: A multicenter cluster-randomized controlled trial.

Diabetes research and clinical practice·2023
Same author

Attitudes and experiences towards the application of motivational interviewing by podiatrists working with people with diabetes at high-risk of developing foot ulcers: a mixed-methods study.

Journal of foot and ankle research·2022
Same author

Using motivational interviewing combined with digital shoe-fitting to improve adherence to wearing orthopedic shoes in people with diabetes at risk of foot ulceration: study protocol for a cluster-randomized controlled trial.

Trials·2021
Same author

Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.

Purinergic signalling·2021
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Thrombolytic therapy for acute myocardial infarction has high failure and reocclusion rates, alongside bleeding risks. Research focuses on improving conventional agents, conjunctive therapies, and developing new plasminogen activators to overcome these challenges.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Acute myocardial infarction (AMI) presents significant challenges in reperfusion therapy.
  • Current thrombolytic treatments for AMI face limitations including primary failure, early reocclusion, and bleeding complications.
  • A substantial percentage of patients are excluded from thrombolytic therapy due to bleeding risks.

Purpose:

  • To address the key problems associated with thrombolytic therapy in acute myocardial infarction.
  • To explore strategies for improving the efficacy and safety of reperfusion treatments.
  • To investigate novel approaches for managing AMI, aiming to minimize treatment-related complications.

Summary:

  • High rates of reperfusion failure (20-40%) and early reocclusion (5-20%) are major issues with current thrombolytic agents in AMI.

Related Experiment Videos

  • Increased risk of bleeding necessitates alternative or improved therapeutic strategies, excluding many patients.
  • Investigational areas include optimizing conventional thrombolytic agents, exploring new conjunctive therapies, and developing advanced plasminogen activators.

    • Impact:

    • Potential for improved patient outcomes in acute myocardial infarction.
    • Development of safer and more effective reperfusion strategies.
    • Reduced morbidity and mortality associated with AMI by overcoming current therapeutic limitations.